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Background: This is a prospective, comparative, pilot and follow-up (2 years post-op) study in 
patients undergoing coronary artery bypass surgery (CABG) where the long saphenous vein (LSV) 
was harvested either by the endoscopic technique (EVH) or open technique (OVH). Quality of life 
(QOL) and major adverse cardiac and cerebro-vascular event (MACCE) were assessed. 
Methods: Alive patients who were initially part of a pilot study when EVH was introduced in our 
institution were included (n= 48 - EVH, n=49 -OVH). Patients were sent a QOL questionnaire 
(SF12v2) and their cardiologist & general practitioner were contacted to assess MACCE. 
Results: Median follow-up was 32 & 33 months respectively. Three patients died (2 EVH, 1 OVH). Of 
the remaining 97 patients who were sent a questionnaire, 76% patients returned the form. More 
patients from the EVH group returned the QOL questionnaire (82% v/s 71%). Time taken to return to 
normal daily activities was much shorter in EVH - median 6 (2,30) weeks compared to OVH - median 
9 (2, 50) weeks (p<0.05). QOL questionnaire revealed significant difference in physical score: 45.3 
(10.2) for EVH group and 40.7 (11.0) for OVH group (p<0.05) at follow-up. There were no difference 
in mental scores (46.9 (10.5) v/s 49.2 (9.1), p = 0.4). There were no significant differences in 
MACCEs including death between the two groups (12.2% v/s 13.9%, p = 0.5).  
Conclusion: EVH patients returned to normal daily activities faster than OVH patients and 
experienced better physical quality of life even after 2-years post-op with no increase in MACCE 
during follow-up. 
 










What is already known about this subject? 
There have been some concerns regarding MACCEs after EVH for CABG. Moreover, QOL after 
CABG has not been reported when based on the technique of LSV harvest 
 
 
What does this study add? 
This manuscript confirmed that MACCE rates were similar between EVH and OVH techniques of LSV 
harvest for CABG. In addition, is also showed that the physical aspect of the QOL was significantly 
better in patients who had EVH for LSV harvest as compared to OVH even 2 years after their surgery.  
 
 
How might this impact on clinical practice? 
This will serve as a pilot study to generate a randomized control trial to confirm these benefits. Once 



















 Coronary artery bypass grafting (CABG) is recognised as one of the options in the 
management of patient with coronary artery disease. The short and long term outcomes after CABG 
are excellent with a very low mortality.[1]. However, the early morbidity from long saphenous vein 
(LSV) harvesting via the open technique (OVH) has been high with leg wound problems reported in 
significant number of patients.[2] and leg wound infection in up to 20%.[3]. The development of 
endoscopic vein harvesting (EVH) has been reported to be associated with better leg wound 
outcomes.[4,5,6]. This has been appraised by NICE (National Institute for Health and Care 
Excellence) and the latest NICE guidelines have endorsed the use of EVH.[7]. 
 However, there were some initial concerns regarding vein graft patency.[8,9] but more recent 
meta-analysis have not supported these concerns.[10]. EVH was introduced to our practice as part of 
service improvement in 2012. The short term benefit of EVH as compared to OVH, in our population 
group has already been proven and included reduction in leg wound problems and infection, a 
reduction in leg wound pain and shorter in-hospital stay.[11]. The benefit of EVH has also been 
supported by the 2014 ESC/EACTS guidelines for myocardial revascularisation.[12]. 
 Currently, there are no randomised control trials or large observational report of QOL after 
EVH reported in the literature.  
 The use of EVH is becoming more popular in the Western World. This technology was 
introduced in our Unit a few years ago and is now used in most patients as there is evidence that 
there has been a significant cost-benefit in our patient group.[11]. 
This study aimed to assess the intermediate outcome including MACCE and quality of life 
(QOL) in the EVH and a matched OVH group.  
METHODS 
 Patients who were initially part of a prospective matched study comparing the initial 
experience with EVH to OVH (n=100) were included. These patients were at high risk of developing 
leg wound problems and had at least two of the following factors: female gender, age over 75 years, 
diabetes, body mass index - BMI > 28 kg/m
2
, smoker and presence of peripheral vascular disease 
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(PVD). Fifty continuous patients who were suitable for EVH were selected for this modality of LSV 
harvest and were matched prospectively with 50 continuous patients who had OVH during the same 
time period.  All patients who were still alive at the time of this current study (n=97) were sent a QOL 
questionnaire (SF12v2) and their cardiologist & general practitioner were contacted to assess 
MACCE based on clinical assessment but not angiography. EVH was performed using the Vasoview 
Haemopro II Endoscopic Vessel Harvesting System (Cardiovascular LLC, Wayne, New Jersey). All 
patients had their cardiac procedure with the use of the cardiopulmonary bypass machine. 
This study was agreed by the Hospital’s Research & Development Department and had the 
Ethical approval (NRES Committee South Central - Oxford, Ref 15/SC/0178). All patients consented 
for their cardiologist/ general practitioner to be approached to determine if there were any MACCE. 
Continuous variables are expressed as mean (SD) or median (minimum, maximum) for 
Gaussian and skewed distributed data respectively. Group comparisons were carried out using the t-
test or non-parametric (Mann-Whitney U) test accordingly. Categorical data are expressed as 
percentage and differences between the two groups assessed using the chi square (χ
2
) test of 
independence. Tests were considered significant at p≤ 0.05. Statistical analyses were carried out in 
SPSS version 20 (IBM, SPSS package).  
RESULTS 
 There were no significant differences in patients’ pre-op characteristics (Table 1).  
  EVH (n=50) OVH (n=50) p-Value 
Age*, years 67.4 (10.6) 68.7 (8.6) 0.6 
Male (%,n) 82%, 41 82%, 41 1 
Patients > 75 years (%,n) 24%, 12 22%, 11 0.9 
Non-diabetic (%,n) 60%, 30 60%, 30 1 
Smokers (%,n) 18%, 9 14%, 7 0.6 
PVD (%,n) 26%, 13 24%, 12 0.9 
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Impaired LVEF (%,n) 32%, 16 38%, 19 0.7 
BMI > 28 kg/m
2
 (%,n) 62%, 31 62%, 31 1 
Elective (%,n) 54%, 27 58%, 29 0.8 
Log EuroScore** 3.92 (0.88,33.63) 4.99 (0.88, 30.1) 0.6 
Isolated CABG (%,n) 78%, 39 76%, 38 0.9 
 
Table 1: The patients’ pre-op characteristics. (EVH: Endoscopic Vein Harvest technique 
OVH: Open Vein Harvest technique, PVD: peripheral vascular disease, LVEF: left ventricular ejection 
fraction, BMI: body mass index, CABG: coronary artery bypass surgery. 
*denotes mean (SD), **denotes median (minimum, maximum)) 
 
 Median follow-up was 32 (28, 43) months and 33 (28,42) months for the EVH and OVH 
groups respectively (p=0.6). Three patients died (2 EVH, 1 OVH) during that period. Of the remaining 
97 patients who were sent a questionnaire, 76% patients returned the form. Interestingly more 
patients from the EVH group returned the QOL questionnaire (82% v/s 71%).  
The time taken to return to normal daily activities was much shorter in EVH - median 6 (2,30) 
weeks compared to OVH - median 9 (2, 50) weeks (p<0.05). QOL questionnaire revealed significant 
difference in physical score: 45.3 (10.2) for EVH group and 40.7 (11.0) for OVH group (p<0.05) at 
follow-up, Figure 1. There were no difference in mental scores (46.9 (10.5) v/s 49.2 (9.1), p = 0.4). 
There were no significant differences in MACCEs including death between the two groups (12.2% v/s 
13.9%, p = 0.5). The MACCE reported for each group is listed in Table 2. 
MACCE Time to event 
EVH group (n=41)   
Death                                                                    immediate post-op: multi-organ failure 
Death                                                                    19 months post-op: pneumonia 
Angina 10 months post-op 
De-compensated cardiac failure                              6 months post-op (poor LVEF pre-op) 
Right occipital small infarct                                  2 weeks post-op 
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OVH group (n=36)   
Death 34 months post-op: heart failure 
AF with de-compensated heart failure                                      3 months post-op 
Angina - stenosis of OM                                                   6 weeks post-op 
Intra-cerebral haemorrhage                            4 weeks post-op 
Heart failure                                            3 months post-op 
 
Table 2: MACCE (major adverse cardiac and cerebro-vascular event) for the two groups. (EVH: 
Endoscopic Vein Harvest technique, OVH: Open Vein Harvest technique, LVEF: left ventricular 
ejection fraction, AF: Atrial Fibrillation, OM: Obtuse marginal artery) 
DISCUSSION 
 This is the first report on quality of life post CABG taking into account the modality of long 
saphenous vein harvest. Previously, QOL post CABG has been compared to PCI,[13,14] where no 
significant differences were reported between the two groups. The effect of on-pump and off-pump 
CABG on QOL has also been assessed and has been shown that there were no significant 
differences between these two groups.[15]. Longitudinal QOL assessment showed an important 
improvement in QOL after CABG.[16]. The effects of age on QOL in CABG have also been 
documented in the literature.[17,18] with the greatest benefit seen in the more elderly population. This 
current study assessed the QOL as a function of the type of LSV harvest (EVH v/s OVH). However, 
there was not a pre-procedure QOL assessment but given that the patients were selected 
continuously and that the two groups were matched on their pre-operative characteristics, the risk of 
any bias would have been minimal. The SF12v2 assessments showed a clear benefit at the time of 
follow-up (median around 32 months) in terms of physical performance, when EVH was used. There 
was no significant impact on mental performance at follow-up between the two techniques (EVH or 
OVH).   
 Persistent leg wound problems even months after CABG, have previously been reported,[19] 
with harvest site pain, numbness and dys-aesthesia. Similar findings were reported by Zhu et al as 
part of a sub-analysis in the RAPCO trial.[2]. In the initial study for the current study group, worst pain 
was also documented in the OVH arm when compared to the EVH arm.[11]. 
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There have been some concerns regarding the patency of LSV grafts when EVH is used. 
These were initially highlighted in the sub-study of the ROOBY trial [8] and also with the PREVENT IV 
trial [9]. However, more recent data with the latest EVH technology suggested that LSV graft patency 
is not affected as compared to OVH.[10,20]. Similar outcomes have been reported when the LSV had 
been harvested by EVH for lower limb vascular procedures.[21]. In the current study, only a small 
percentage of patients post CABG had either an ischaemic event or evidence of blocked grafts on 
angiography: 2.4% (1/41) for EVH and 2.8% (1/36) for OVH. 
 Overall MACCE rates in this current study were 12.2% (EVH) v/s 13.9% (OVH). This rate is 
fairly similar to those reported in the NOBLE trial - 19% for CABG at 5 years.[22] Thus, within this 
small series, EVH use was not associated with an increased MACCE rate. 
Limitations 
 This was a single centre, pilot study. Moreover, pre-operative QOL data was not available for 
both groups of patients. Treatment assignments were not blinded. Knowledge of treatment status may 
have affected QOL responses. QOL measures reflect a subjective assessment of health status; 
participants from diverse cultures may attach different significance to symptoms/limitations. Because 
of lack of randomization, such differences could have affected the scores. Many biologic and 
socioeconomic factors not included in this analysis may also impact QOL. 
CONCLUSION  
 EVH patients returned to normal daily activities faster than OVH patients. The former also 
experienced better physical quality of life even after 2-years post-op with no increase in MACCE 
during follow-up when compared to OVH patients. However, given that is was only a pilot study 
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Figure 1:  Physical scores (SF12v2) of the EVH and OVH groups 
 
 
